Does low morning cortisol make below-optimal free T3 more clinically relevant?

The bidirectional relationship between the hypothalamic-pituitary-adrenal (HPA) axis and the hypothalamic-pituitary-thyroid (HPT) axis critically shapes systemic metabolism, energy production, and clinical management.

Endocrine and metabolic mechanisms

• Central HPT-axis signaling: Glucocorticoids exert powerful regulatory feedback on thyroid signaling. While hypercortisolemia suppresses hypothalamic TRH mRNA and pituitary TSH secretion, hypocortisolemia (low morning cortisol) removes this normal glucocorticoid-mediated inhibition, frequently resulting in a mild, transient elevation of TSH.
• Peripheral thyroid metabolism: Cortisol levels directly program tissue-specific deiodinase enzyme activities. High cortisol levels suppress type 1 (D1) and type 2 (D2) deiodinases while upregulating type 3 (D3) deiodinase, reducing the conversion of thyroxine (T4) to active triiodothyronine (T3). Conversely, low cortisol shifts peripheral deiodination in the opposite direction, increasing systemic T4-to-T3 conversion and reducing reverse T3 (rT3), though it may decrease local D2 activity in the brain.

Clinical implications and safety

• Symptomatic synergy: Free T3 regulates basal metabolic rate and mitochondrial energy production, while cortisol mobilizes fuel substrates. When low morning cortisol and below-optimal free T3 coexist, their overlapping actions synergize to produce profound fatigue, severe metabolic exhaustion, and orthostatic intolerance.
• Adrenal crisis risk: Thyroid hormones directly regulate and accelerate the metabolic clearance of cortisol. Initiating thyroid hormone replacement in a patient with untreated hypocortisolemia can rapidly deplete remaining cortisol reserves, potentially precipitating a life-threatening adrenal crisis. Consequently, establishing and treating cortisol status is a critical prerequisite before correcting below-optimal thyroid levels.

Bottom line

• Below-optimal free T3 is highly relevant in the setting of low morning cortisol because their combination severely amplifies metabolic fatigue, and initiating thyroid therapy without first addressing adrenal insufficiency risks triggering a fatal adrenal crisis.